ATORVASTATIN CALCIUM

206602 reported adverse events

Drug classes: HMG-CoA Reductase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ATORVASTATIN CALCIUM:

# Side effect Count
0 TYPE 2 DIABETES MELLITUS 11132
1 DRUG INEFFECTIVE 10843
2 FATIGUE 10660
3 NAUSEA 10058
4 MYALGIA 8777
5 DYSPNOEA 8570
6 DIARRHOEA 8445
7 PAIN 8102
8 DIZZINESS 7875
9 ASTHENIA 7220
See all common reactions for ATORVASTATIN CALCIUM

ATORVASTATIN CALCIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TYPE 2 DIABETES MELLITUS 11132 0.4271
1 NEUROLOGIC NEGLECT SYNDROME 128 0.3844
2 IMMUNE-MEDIATED NECROTISING MYOPATHY 149 0.2719
3 IMMUNE-MEDIATED MYOSITIS 205 0.2253
4 CAROTID ARTERY THROMBOSIS 130 0.2249
5 HYPERTENSIVE EMERGENCY 134 0.1558
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 129 0.1352
7 ADJUSTMENT DISORDER 128 0.1343
8 HIGH DENSITY LIPOPROTEIN DECREASED 356 0.1280
9 NEPHROGENIC ANAEMIA 537 0.1252
See all enriched reactions for ATORVASTATIN CALCIUM